A Dose-Ranging Study of the Efficacy of ABT-894 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Earle Bain, MD
Abbott
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Site Reference Id/investigator# 5965
San Francisco, California, United States
- Site Reference Id/investigator# 5955
Wildomar, California, United States
- Site Reference Id/investigator# 5974
Orlando, Florida, United States
- Site Reference Id/investigator# 5956
West Palm Beach, Florida, United States
- Site Reference Id/investigator# 5973
Libertyville, Illinois, United States
- Site Reference Id/investigator# 5968
Overland Park, Kansas, United States
- Site Reference Id/investigator# 5952
Rockville, Maryland, United States
- Site Reference Id/investigator# 5962
Boston, Massachusetts, United States
- Site Reference Id/investigator# 5954
Okemos, Michigan, United States
- Site Reference Id/investigator# 5970
Troy, Michigan, United States
- Site Reference Id/investigator# 5960
Clementon, New Jersey, United States
- Site Reference Id/investigator# 5963
Charlotte, North Carolina, United States
- Site Reference Id/investigator# 5975
Eugene, Oregon, United States
- Site Reference Id/investigator# 5971
Philadelphia, Pennsylvania, United States
- Site Reference Id/investigator# 5957
Charleston, South Carolina, United States
- Site Reference Id/investigator# 5972
Austin, Texas, United States
- Site Reference Id/investigator# 5959
Bellaire, Texas, United States
- Site Reference Id/investigator# 5969
San Antonio, Texas, United States
- Site Reference Id/investigator# 5951
Salt Lake City, Utah, United States
- Site Reference Id/investigator# 5964
Burlington, Vermont, United States
- Site Reference Id/investigator# 5953
Virginia Beach, Virginia, United States
- Site Reference Id/investigator# 5958
Bellevue, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2007
- Primary completion
- 31 Aug 2007
- Completion
- —
- Last update posted
- 2 Nov 2010
- Registered enrollment
- 243
- Registry id
- NCT00429091
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.